Currently, Aurora Cannabis Inc [ACB] is trading at $5.22, down -2.25%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ACB shares have gain 3.57% over the last week, with a monthly amount glided 22.54%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Canaccord Genuity upgraded its rating to Buy on February 09, 2024. On September 21, 2022, upgrade upgraded it’s rating to Hold. Cantor Fitzgerald upgraded its rating to a Overweight. Stifel upgraded its rating to a Hold. MKM Partners upgraded its rating to Neutral for this stock on September 28, 2021. In a note dated September 03, 2021, Jefferies upgraded an Hold rating on this stock and revised its target price from $7.49 to $6.78.
This stock has fluctuated between a low of $3.42 and a high of $7.57 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $5.92 within the next 12 months. Aurora Cannabis Inc [NASDAQ: ACB] shares were valued at $5.22 at the most recent close of the market. An investor can expect a potential return of 13.41% based on the average ACB price forecast.
Analyzing the ACB fundamentals
Trailing Twelve Months sales for Aurora Cannabis Inc [NASDAQ:ACB] were 233.51M which represents 33.35% growth. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at -0.11%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.06 and Total Capital is -0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aurora Cannabis Inc [NASDAQ:ACB] is 3.30. As well, the Quick Ratio is 1.60, while the Cash Ratio is 0.91. Considering the valuation of this stock, the price to sales ratio is 1.23, the price to book ratio is 0.72 and price to earnings (TTM) ratio is 33.12.
